Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A3 pseudogene 3 (NDUFA3P3) is a processed pseudogene related in sequence to the functional NADH:ubiquinone oxidoreductase subunit A3 gene. Like most pseudogenes, NDUFA3P3 does not encode a functional protein and is typically considered a nonfunctional genomic remnant. However, some pseudogenes have been implicated in regulating biological processes by producing regulatory RNAs or acting as decoys for microRNAs, thereby influencing gene expression. There is currently no evidence that NDUFA3P3 itself is a therapeutic target or a significant disease biomarker, nor is it known to interact with any drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A3 pseudogene 3 (NDUFA3P3).